Evidence map›Paper›PMID 37209240›Full record

ArticleJournal of cancer survivorship : research and practice2024

Benign and malignant pulmonary parenchymal findings on chest CT among adult survivors of childhood and young adult cancer with a history of chest radiotherapy.

Dana Barnea, Emily S Tonorezos, Amber Khan, Joanne F Chou, Chaya S Moskowitz, Rana Kaplan, Suzanne L Wolden, Yolanda Bryce, Kevin C Oeffinger

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Dana BarneaDepartment of Hematology, Tel Aviv Sourasky Medical Center, 6 Weizmann St, 64239, Tel Aviv, Israel. danaba@tlvmc.gov.il.
Emily S TonorezosOffice of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
Amber KhanDepartment of Psychiatry and Behavioral Sciences, Montefiore Medical Center-Albert Einstein College of Medicine, New York, NY, USA.
Joanne F ChouDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Chaya S MoskowitzDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Rana KaplanDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Suzanne L WoldenDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yolanda BryceDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kevin C OeffingerDepartment of Medicine, Duke University, Durham, NC, USA.
Memorial Sloan Kettering Cancer Center · USDuke University · USMontefiore Medical Center · USNational Cancer Institute · USTel Aviv Sourasky Medical Center · IL

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Survivorship: Mentoring and Bridging Primary Care and OncologyK05CA160724 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI OEFFINGER, KEVIN CHARLES · 2011 to 2015
$821k
NCI NIH HHS K05 CA160724NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeChildhood and young adult cancer survivors exposed to chest radiotherapy are at increased risk of lung cancer. In other high-risk populations, lung cancer screening has been recommended. Data is lacking on prevalence of benign and malignant pulmonary parenchymal abnormalities in this population.

methodsWe conducted a retrospective review of pulmonary parenchymal abnormalities in chest CTs performed more than 5 years post-cancer diagnosis in survivors of childhood, adolescent, and young adult cancer. We included survivors exposed to radiotherapy involving the lung field and followed at a high-risk survivorship clinic between November 2005 and May 2016. Treatment exposures and clinical outcomes were abstracted from medical records. Risk factors for chest CT-detected pulmonary nodule were assessed.

resultsFive hundred and ninety survivors were included in this analysis: median age at diagnosis, 17.1 years (range, 0.4-39.8); and median time since diagnosis, 22.3 years (range, 1-58.6). At least one chest CT more than 5 years post-diagnosis was performed in 338 survivors (57%). Among these, 193 (57.1%) survivors had at least one pulmonary nodule detected on a total of 1057 chest CTs, resulting in 305 CTs with 448 unique nodules. Follow-up was available for 435 of these nodules; 19 (4.3%) were malignant. Risk factors for first pulmonary nodule were older age at time of CT, CT performed more recently, and splenectomy.

conclusionsBenign pulmonary nodules are very common among long-term survivors of childhood and young adult cancer. IMPLICATIONS FOR CANCER SURVIVORS: High prevalence of benign pulmonary nodules in cancer survivors exposed to radiotherapy could inform future guidelines on lung cancer screening in this population.

Indexed as

Cancer SurvivorsLung NeoplasmsTomography, X-Ray ComputedAdolescentAdultChildChild, PreschoolFemaleHumansInfantMaleNeoplasmsRadiotherapyRetrospective StudiesYoung AdultCancer survivorChest CTLung cancerPulmonary nodule

Identifiers

PMID37209240
PMCPMC11973493
OpenAlexW4377137277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.